Skip to main content
Top
Published in: Obesity Surgery 10/2015

01-10-2015 | Original Contributions

Cardiovascular Changes After Gastric Bypass Surgery: Involvement of Increased Secretions of Glucagon-Like Peptide-1 and Brain Natriuretic Peptide

Published in: Obesity Surgery | Issue 10/2015

Login to get access

Abstract

Background

Obesity induces cardiovascular alterations, including cardiac hypertrophy, impaired relaxation, and heart rate variability (HRV), which are associated with increased mortality. Gastric bypass surgery (GBP) reduces cardiovascular mortality, but the mechanisms involved are not clearly established. To date, the implication of postsurgical hormonal changes has not been tested. Our aim was to study the relationships between the evolution of cardiovascular functions after GBP and changes in metabolic and hormonal parameters, including glucagon-like peptide-1 (GLP-1) and brain natriuretic peptide (N-terminal pro-brain natriuretic peptide (NT-proBNP)).

Methods

Echocardiographic parameters, 24-h rhythmic Holter recording, plasma concentrations of GLP-1 before and after a test meal, and fasting NT-proBNP were assessed in 34 patients (M/F 2/32, age 36 ± 11 years, BMI 46 ± 6 kg/m2), before and 1 year after GBP.

Results

After GBP, excess weight loss was 79 ± 20 %. Blood pressure (BP), heart rate, and left ventricular mass decreased, while HRV and diastolic function (E/A ratio) improved. Plasma concentrations of NT-proBNP and postprandial (PP) GLP-1 increased. Changes in cardiovascular parameters were related to BMI and insulin sensitivity. Furthermore, the decrease in BP was independently associated with the increase of PP GLP-1 level and HRV was positively associated with NT-proBNP concentration after surgery.

Conclusions

The increase in endogenous GLP-1 observed after GBP was associated with decreased BP but not with improvement of other cardiovascular parameters, whereas the increase in NT-proBNP, within the physiological range, was associated with improved HRV.
Literature
1.
go back to reference Algahim MF, Sen S, Taegtmeyer H. Bariatric surgery to unload the stressed heart: a metabolic hypothesis. Am J Physiol Heart Circ Physiol. 2012;302(8):H1539–H45.PubMedCentralCrossRefPubMed Algahim MF, Sen S, Taegtmeyer H. Bariatric surgery to unload the stressed heart: a metabolic hypothesis. Am J Physiol Heart Circ Physiol. 2012;302(8):H1539–H45.PubMedCentralCrossRefPubMed
3.
go back to reference Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34.CrossRefPubMed Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34.CrossRefPubMed
4.
go back to reference Grapsa J, Tan TC, Paschou SA, et al. The effect of bariatric surgery on echocardiographic indices: a review of the literature. Eur J Clin Investig. 2013;43(11):1224–30. Grapsa J, Tan TC, Paschou SA, et al. The effect of bariatric surgery on echocardiographic indices: a review of the literature. Eur J Clin Investig. 2013;43(11):1224–30.
5.
go back to reference Hsuan C-F, Huang C-K, Lin J-W, et al. The effect of surgical weight reduction on left ventricular structure and function in severe obesity. Obesity. 2010;18(6):1188–93.CrossRefPubMed Hsuan C-F, Huang C-K, Lin J-W, et al. The effect of surgical weight reduction on left ventricular structure and function in severe obesity. Obesity. 2010;18(6):1188–93.CrossRefPubMed
6.
go back to reference Kardassis D, Grote L, Sjöström L, et al. Sleep apnea modifies the long-term impact of surgically induced weight loss on cardiac function and inflammation. Obesity. 2013;21(4):698–704.CrossRefPubMed Kardassis D, Grote L, Sjöström L, et al. Sleep apnea modifies the long-term impact of surgically induced weight loss on cardiac function and inflammation. Obesity. 2013;21(4):698–704.CrossRefPubMed
7.
go back to reference Maser RE, Lenhard MJ, Peters MB, et al. Effects of surgically induced weight loss by Roux-en-Y gastric bypass on cardiovascular autonomic nerve function. Surg Obes Relat Dis. 2013;9(2):221–6.CrossRefPubMed Maser RE, Lenhard MJ, Peters MB, et al. Effects of surgically induced weight loss by Roux-en-Y gastric bypass on cardiovascular autonomic nerve function. Surg Obes Relat Dis. 2013;9(2):221–6.CrossRefPubMed
8.
go back to reference Algahim MF, Lux TR, Leichman JG, et al. Progressive regression of left ventricular hypertrophy two years after bariatric surgery. Am J Med. 2010;123(6):549–55.PubMedCentralCrossRefPubMed Algahim MF, Lux TR, Leichman JG, et al. Progressive regression of left ventricular hypertrophy two years after bariatric surgery. Am J Med. 2010;123(6):549–55.PubMedCentralCrossRefPubMed
9.
go back to reference Straznicky NE, Grima MT, Sari CI, et al. The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome. J Clin Endocrinol Metab. 2013;98(2):E227–E37.CrossRefPubMed Straznicky NE, Grima MT, Sari CI, et al. The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome. J Clin Endocrinol Metab. 2013;98(2):E227–E37.CrossRefPubMed
11.
go back to reference Changchien E, Ahmed S, Betti F, et al. B-type natriuretic peptide increases after gastric bypass surgery and correlates with weight loss. Surg Endosc. 2011;25(7):2338–43.CrossRefPubMed Changchien E, Ahmed S, Betti F, et al. B-type natriuretic peptide increases after gastric bypass surgery and correlates with weight loss. Surg Endosc. 2011;25(7):2338–43.CrossRefPubMed
12.
go back to reference Abrahamsson N, Engström B, Sundbom M, et al. Gastric bypass surgery elevates NT-ProBNP levels. Obes Surg. 2013;23(9):1421–6. Abrahamsson N, Engström B, Sundbom M, et al. Gastric bypass surgery elevates NT-ProBNP levels. Obes Surg. 2013;23(9):1421–6.
13.
go back to reference Martin J, Bergeron S, Pibarot P, et al. Impact of bariatric surgery on N-terminal fragment of the prohormone brain natriuretic peptide and left ventricular diastolic Function. Can J Cardiol. 2013;29(8):969–75.CrossRefPubMed Martin J, Bergeron S, Pibarot P, et al. Impact of bariatric surgery on N-terminal fragment of the prohormone brain natriuretic peptide and left ventricular diastolic Function. Can J Cardiol. 2013;29(8):969–75.CrossRefPubMed
14.
go back to reference Coupaye M, Sabate JM, Castel B, et al. Predictive factors of weight loss 1 year after laparoscopic gastric bypass in obese patients. Obes Surg. 2010;20(12):1671–7.CrossRefPubMed Coupaye M, Sabate JM, Castel B, et al. Predictive factors of weight loss 1 year after laparoscopic gastric bypass in obese patients. Obes Surg. 2010;20(12):1671–7.CrossRefPubMed
15.
go back to reference Spencer KT, Kimura BJ, Korcarz CE, et al. Focused cardiac ultrasound: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2013;26(6):567–81.CrossRefPubMed Spencer KT, Kimura BJ, Korcarz CE, et al. Focused cardiac ultrasound: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2013;26(6):567–81.CrossRefPubMed
16.
go back to reference Teichholz LE, Kreulen T, Herman MV, et al. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol. 1976;37(1):7–11.CrossRefPubMed Teichholz LE, Kreulen T, Herman MV, et al. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol. 1976;37(1):7–11.CrossRefPubMed
17.
go back to reference Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450–8.CrossRefPubMed Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450–8.CrossRefPubMed
18.
go back to reference Laville M, Romon M, Chavrier G, et al. Recommendations regarding obesity surgery. Obes Surg. 2005;15(10):1476–80.CrossRefPubMed Laville M, Romon M, Chavrier G, et al. Recommendations regarding obesity surgery. Obes Surg. 2005;15(10):1476–80.CrossRefPubMed
19.
go back to reference Yeo I-K, Johnson R. A new family of power transformations to improve normality or symmetry. Biometrika. 2000;87:954–9.CrossRef Yeo I-K, Johnson R. A new family of power transformations to improve normality or symmetry. Biometrika. 2000;87:954–9.CrossRef
20.
go back to reference Vest AR, Heneghan HM, Agarwal S, et al. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98(24):1763–77.CrossRefPubMed Vest AR, Heneghan HM, Agarwal S, et al. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98(24):1763–77.CrossRefPubMed
21.
go back to reference Nathanson D, Zethelius B, Berne C, et al. Plasma levels of glucagon like peptide-1 associate with diastolic function in elderly men. Diabet Med. 2011;28(3):301–5.PubMed Nathanson D, Zethelius B, Berne C, et al. Plasma levels of glucagon like peptide-1 associate with diastolic function in elderly men. Diabet Med. 2011;28(3):301–5.PubMed
22.
go back to reference Katout M, Zhu H, Rutsky J, et al. Effect of GLP-1 mimetics on blood pressure and relationship to weight loss and glycemia lowering: results of a systematic meta-analysis and meta-regression. Am J Hypertens. 2014;27(1):130–9.CrossRefPubMed Katout M, Zhu H, Rutsky J, et al. Effect of GLP-1 mimetics on blood pressure and relationship to weight loss and glycemia lowering: results of a systematic meta-analysis and meta-regression. Am J Hypertens. 2014;27(1):130–9.CrossRefPubMed
23.
go back to reference Griffioen KJ, Wan R, Okun E, et al. GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons. Cardiovasc Res. 2011;89(1):72–8.PubMedCentralCrossRefPubMed Griffioen KJ, Wan R, Okun E, et al. GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons. Cardiovasc Res. 2011;89(1):72–8.PubMedCentralCrossRefPubMed
24.
go back to reference Kim M, Platt MJ, Shibasaki T, et al. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure. Nat Med. 2013;19(5):567–75.CrossRefPubMed Kim M, Platt MJ, Shibasaki T, et al. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure. Nat Med. 2013;19(5):567–75.CrossRefPubMed
25.
go back to reference Khan AM, Cheng S, Magnusson M, et al. Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J Clin Endocrinol Meta. 2011;96(10):3242–9.CrossRef Khan AM, Cheng S, Magnusson M, et al. Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J Clin Endocrinol Meta. 2011;96(10):3242–9.CrossRef
Metadata
Title
Cardiovascular Changes After Gastric Bypass Surgery: Involvement of Increased Secretions of Glucagon-Like Peptide-1 and Brain Natriuretic Peptide
Publication date
01-10-2015
Published in
Obesity Surgery / Issue 10/2015
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-015-1643-5

Other articles of this Issue 10/2015

Obesity Surgery 10/2015 Go to the issue

Original Contributions

Bariatric Surgery Worldwide 2013